Pharmaceutical manufacturers are padding their wallets while rural families and retirees are squeezed by a system designed to benefit shareholders, not patients,” writes Tonja Hanson in an op-ed.

The Trump administration is experiencing some cognitive dissonance: The new president’s Justice Department is going to bat ...

Jazz Pharmaceuticals’ acquisition of Chimerix brings a drug that could become the first approved therapy for a rare and ...

"Competition plays a crucial role in determining drug prices. When a new cancer drug is introduced by a single manufacturer, its cost is typically high due to research and development costs.

Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic drug supplies.

Bristol Myers Squibb said it will acquire its struggling CAR-T partner 2Seventy Bio for $286 million, or $102 million net of ...

The company has asked the U.S. patent office to reconsider patents that could prevent it from selling an update to Keytruda.

In a notification issued on Sunday, the NBR said it had slashed the tax at source on the import of ingredients for oncology ...

Pfizer (NYSE:PFE) stock and Arvinas (NASDAQ:ARVN) stock slip in reaction to mixed Phase 3 data for their breast cancer drug ...

New Delhi: Cancer patients facing prohibitive treatment costs in India can hope for relief: the nation's top drugmakers have ...